SCHEMBL18939149

SCHEMBL18939149

O=C(O)NC(=O)Nc1cc(F)c(Cn2ccc3ncccc32)c(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.40
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
NR1I2 O75469 1/20 0.38
SLC22A12 Q96S37 1/20 0.37
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
HTT P42858 1/20 0.35
NR3C1 P04150 1/20 0.35
NR3C2 P08235 1/20 0.35
RORC P51449 3/20 0.35
PTGER3 P43115 2/20 0.35
GRIN2B Q13224 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18939071 0.81 FLT1 (0.52) KDM4EALDH1A1MAPK1MEN1KMT2A
SCHEMBL18939145 0.81 FLT1 (0.43) KDM4EALDH1A1MAPK1MEN1KMT2A
SCHEMBL18977913 0.78 GRIN2B (0.43) METMAPK1MEN1KMT2ASLC22A12
Hydrochloric Acid SCHEMBL18939169 0.77 SLC22A12 (0.45) METSLC22A12RORCGRIN2B
SCHEMBL18939032 0.76 MET (0.40) METALDH1A1MAPK1MEN1KMT2A
SCHEMBL18967497 0.74 SLC22A12 (0.36) METMEN1KMT2AMAPTSLC22A12
SCHEMBL18939015 0.74 PLAU (0.41) METSLC22A12NR3C1NR3C2RORC
SCHEMBL18939091 0.73 RPS6KA5 (0.41) METSLC22A12GRIN2BCYP1A2CYP2C9
SCHEMBL18960814 0.72 SLC22A12 (0.37) METMAPK1MAPTSLC22A12LMNA
SCHEMBL18960813 0.72 SLC22A12 (0.38) METALDH1A1SLC22A12NR3C1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE48097-E1 Cephem compounds, their production and use NAEJA-RGM PHARMACEUTICALS ULC (CA) 2020-07-14 US disclosed
US-9751894-B2 Cephem compounds, their production and use NAEJA-RGM PHARMACEUTICALS INC. (CA) 2017-09-05 US disclosed
US-20170166587-A1 CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE NAEJA-RGM PHARMACEUTICALS ULC (CA) 2017-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170166587-A1 CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE CEP170, AADAC, NAA50 MET 1902/4885KDM4E 1024/4885ALDH1A1 4150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.